Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
about
Interactions of dendrimers with biological drug targets: reality or mystery - a gap in drug delivery and development research.Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies.In vivo proinflammatory activity of generations 0-3 (G0-G3) polyamidoamine (PAMAM) nanoparticles.
P2860
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
@en
type
label
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
@en
prefLabel
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
@en
P2093
P356
P1476
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis
@en
P2093
Alina Kotlyar
Alisa E Koch
Asish C Misra
Ingrid L Bergin
Istvan Majoros
James R Baker
Jingga Morry
Michael Beer
Paul Makidon
Phil Campbell
P304
P356
10.1166/JBN.2015.2077
P577
2015-08-01T00:00:00Z